Category Specific RSS

News

Harris Tech report $1m revenue from opportunistic sanitary sales

When Harris Technology (ASX: HT8) started selling sanitary products amidst the global demand surge brought upon by the coronavirus pandemic, they estimated Q4 sales of around $400,000. Today they reported they have sold more than $1 million worth of their Pro-Hygiene products in April alone.

Whilst IT and electronics are Harris Technology’s flagship products, they made up just 61% of the Company’s $2.72m sales in April 2020. Comparatively, Harris Technology reported $3.4m in sales through Q3, highlighting the sales growth through April driven by the increase in home office sales from people working at home, and hygiene products brought upon by COVID-19. 

The sales revenue follows a common trend amongst ASX-listed companies in 2020 which have pivoted their product offerings to capitalise on COVID-19 thematics. 

With the sudden growth of Harris Technology’s new business, the Company has appointed sales agents in each Australian State whilst launching a new website to better delineate the products from their IT and e-commerce business. 

Although social isolation restrictions are expected to be eased over the coming months, it is expected that many workers will continue working from home for the foreseeable future, driving demand for home office products. 

Alongside this, Harris Technology anticipate sales of their Pro-Hygiene range to remain strong with products predominantly sourced from China to be sold in Australia with an average profit margin of 20%. 

Following news of their impressive sanitary sales through April, shares in HT8 rose to an intraday high of $0.055, a rise of 83% on their previous days close of $0.03.

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

5 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago